References
Key articles
Go RS, Winters JL, Kay NE. How I treat autoimmune hemolytic anemia. Blood. 2017 Jun 1;129(22):2971-9 Abstract
Hill QA, Stamps R, Massey E, et al. The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol. 2017 Feb;176(3):395-411.Full text Abstract
Hill QA, Stamps R, Massey E, et al. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol. 2017 Apr;177(2):208-20.Full text Abstract
Reference articles
1. Kim Y, Park J, Kim M. Diagnostic approaches for inherited hemolytic anemia in the genetic era. Blood Res. 2017 Jun;52(2):84-94.Full text Abstract
2. Jung HL. A new paradigm in the diagnosis of hereditary hemolytic anemia. Blood Res. 2013 Dec;48(4):237-9.Full text Abstract
3. Nkhoma ET, Poole C, Vannappagari V, et al. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009 May-Jun;42(3):267-78.Full text Abstract
4. Lippi G, Mattiuzzi C. Updated worldwide epidemiology of inherited erythrocyte disorders. Acta Haematol. 2020;143(3):196-203. Abstract
5. Beutler E. Red cell enzyme defects. Hematol Pathol. 1990;4(3):103-14. Abstract
6. Heller P, Best WR, Nelson RB, et al. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med. 1979 May 3;300(18):1001-5. Abstract
7. Prchal JT, Gregg XT. Red cell enzymes. Hematology Am Soc Hematol Educ Program. 2005 Jan 1;1:19-23.Full text Abstract
8. Barcellini W, Fattizzo B. How I treat warm autoimmune hemolytic anemia. Blood. 2021 Mar 11;137(10):1283-94.Full text Abstract
9. Tranekær S, Hansen DL, Frederiksen H. Epidemiology of secondary warm autoimmune haemolytic anaemia: a systematic review and meta-analysis. J Clin Med. 2021 Mar 17;10(6):1244.Full text Abstract
10. Go RS, Winters JL, Kay NE. How I treat autoimmune hemolytic anemia. Blood. 2017 Jun 1;129(22):2971-9 Abstract
11. Kalfa TA. Warm antibody autoimmune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):690-7.Full text Abstract
12. Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2009 Jan 1;1:73-9.Full text Abstract
13. Durán S, Apte M, Alarcón GS, et al. Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort. Arthritis Rheum. 2008 Sep 15;59(9):1332-40.Full text Abstract
14. Giannini S, Martes C. Anemia in inflammatory bowel disease. Minerva Gastroenterol Dietol. 2006 Sep;52(3):275-91. Abstract
15. Sallah S, Sigounas G, Vos P, et al. Autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma: characteristics and significance. Ann Oncol. 2000 Dec;11(12):1571-7.Full text Abstract
16. Autore F, Pasquale R, Innocenti I, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: a comprehensive review. Cancers (Basel). 2021 Nov 19;13(22):5804.Full text Abstract
17. Hodgson K, Ferrer G, Montserrat E, et al. Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematologica. 2011 May;96(5):752-61.Full text Abstract
18. Zhou JC, Wu MQ, Peng ZM, et al. Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia: a retrospective study. Medicine (Baltimore). 2020 Feb;99(7):e19015.Full text Abstract
19. Ravindran A, Sankaran J, Jacob EK, et al. High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia. Am J Hematol. 2017 Aug;92(8):E164-6.Full text Abstract
20. Palatianos GM, Laczkovics AM, Simon P, et al. Multicentered European study on safety and effectiveness of the On-X prosthetic heart valve: intermediate follow-up. Ann Thorac Surg. 2007 Jan;83(1):40-6.Full text Abstract
21. Bavaria JE, Desai ND, Cheung A, et al. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study. J Thorac Cardiovasc Surg. 2014 Feb;147(2):590-7.Full text Abstract
22. Alkhouli M, Farooq A, Go RS, et al. Cardiac prostheses-related hemolytic anemia. Clin Cardiol. 2019 Jul;42(7):692-700.Full text Abstract
23. Steensma DP, Hoyer JD, Fairbanks VF. Hereditary red blood cell disorders in middle eastern patients. Mayo Clin Proc. 2001 Mar;76(3):285-93. Abstract
24. Ryan K, Bain BJ, Worthington D, et al. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010 Apr;149(1):35-49.Full text Abstract
25. Parker CJ. Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):208-16.Full text Abstract
26. Berentsen S, Barcellini W. Autoimmune hemolytic anemias. N Engl J Med. 2021 Oct 7;385(15):1407-19. Abstract
27. Boilève A, Gavaud A, Grignano E, et al. Acute and fatal cephalosporin-induced autoimmune haemolytic anaemia. Br J Clin Pharmacol. 2021 Apr;87(4):2152-6.Full text Abstract
28. Lee SW, Chaiyakunapruk N, Lai NM. What G6PD-deficient individuals should really avoid. Br J Clin Pharmacol. 2017 Jan;83(1):211-2.Full text Abstract
29. Telford RD, Sly GJ, Hahn AG, et al. Footstrike is the major cause of hemolysis during running. J Appl Physiol (1985). 2003 Jan;94(1):38-42.Full text Abstract
30. Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol. 2009;2009:495863.Full text Abstract
31. Jang HN, Bae EJ, Hwang K, et al. Hemolytic uremic syndrome associated with paraquat intoxication. J Clin Apher. 2014 Jun;29(3):183-6. Abstract
33. Rajapakse P, Bakirhan K. Autoimmune hemolytic anemia associated with human babesiosis. J Hematol. 2021 Apr;10(2):41-5.Full text Abstract
34. Hubl W, Mostbeck B, Hartleb H, et al. Investigation of the pathogenesis of massive hemolysis in a case of Clostridium perfringens septicemia. Ann Hematol. 1993 Sep;67(3):145-7. Abstract
35. Hashiba M, Tomino A, Takenaka N, et al. Clostridium perfringens infection in a febrile patient with severe hemolytic anemia. Am J Case Rep. 2016 Apr 6;17:219-23.Full text Abstract
36. Shurin SB, Anderson P, Zollinger J, et al. Pathophysiology of hemolysis in infections with Haemophilus influenzae type b. J Clin Invest. 1986 Apr;77(4):1340-8.Full text Abstract
37. Hill QA, Stamps R, Massey E, et al. The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol. 2017 Feb;176(3):395-411.Full text Abstract
38. Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Rev. 2020 May;41:100648. Abstract
39. Williams JD, Jayaprakash RK, Kithany H, et al. How to use Donath-Landsteiner test to diagnose paroxysmal cold haemoglobinuria (PCH). Arch Dis Child Educ Pract Ed. 2022 Jun;107(3):199-206.Full text Abstract
40. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med. 2018;56(12):2015-38. Abstract
41. Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood. 1987 Mar;69(3):820-6.Full text Abstract
42. Bain BJ. Diagnosis from the blood smear. N Engl J Med. 2005 Aug 4;353(5):498-507. Abstract
43. Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA. 1980 May 16;243(19):1909-11. Abstract
44. Galen RS. Application of the predictive value model in the analysis of test effectiveness. Clin Lab Med. 1982 Dec;2(4):685-99. Abstract
45. Oppenheim A, Jury CL, Rund D, et al. G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews. Hum Genet. 1993 Apr;91(3):293-4. Abstract
46. Reynaud Q, Durieu I, Dutertre M, et al. Efficacy and safety of rituximab in auto-immune hemolytic anemia: a meta-analysis of 21 studies. Autoimmun Rev. 2015 Apr;14(4):304-13. Abstract
47. Liu AP, Cheuk DK. Disease-modifying treatments for primary autoimmune haemolytic anaemia. Cochrane Database Syst Rev. 2021 Mar 26;3(3):CD012493.Full text Abstract
48. Bussone G, Ribeiro E, Dechartres A, et al. Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases. Am J Hematol. 2009 Mar;84(3):153-7.Full text Abstract
49. Hill QA, Stamps R, Massey E, et al. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol. 2017 Apr;177(2):208-20.Full text Abstract
50. Salama A. Drug-induced immune hemolytic anemia. Expert Opin Drug Saf. 2009 Jan;8(1):73-9. Abstract
51. Scully M, Cataland S, Coppo P, et al. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost. 2017 Feb;15(2):312-22.Full text Abstract
52. Zheng XL, Vesely SK, Cataland SR, et al. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020 Oct;18(10):2496-502.Full text Abstract
53. Martí-Carvajal AJ, Anand V, Cardona AF, et al. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. Cochrane Database Syst Rev. 2014 Oct 30;(10):CD010340.Full text Abstract
54. Habermalz B, Sauerland S, Decker G, et al. Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2008 Apr;22(4):821-48. Abstract
55. Cai Y, Liu Z, Liu X. Laparoscopic versus open splenectomy for portal hypertension: a systematic review of comparative studies. Surg Innov. 2014 Aug;21(4):442-7. Abstract
56. Zheng X, Dou C, Yao Y, et al. A meta-analysis study of laparoscopic versus open splenectomy with or without esophagogastric devascularization in the management of liver cirrhosis and portal hypertension. J Laparoendosc Adv Surg Tech A. 2015 Feb;25(2):103-11. Abstract
57. Iolascon A, Andolfo I, Barcellini W, et al. Recommendations regarding splenectomy in hereditary hemolytic anemias. Haematologica. 2017 Aug;102(8):1304-13.Full text Abstract
58. Recht J, Chansamouth V, White NJ, et al. Nitrofurantoin and glucose-6-phosphate dehydrogenase deficiency: a safety review. JAC Antimicrob Resist. 2022 Jun;4(3):dlac045.Full text Abstract
59. Belfield KD, Tichy EM. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency. Am J Health Syst Pharm. 2018 Feb 1;75(3):97-104. Abstract
60. Grace RF, Barcellini W. Management of pyruvate kinase deficiency in children and adults. Blood. 2020 Sep 10;136(11):1241-9.Full text Abstract
61. Al-Samkari H, Galactéros F, Glenthøj A, et al. Mitapivat versus placebo for pyruvate kinase deficiency. N Engl J Med. 2022 Apr 14;386(15):1432-42. Abstract
62. Glenthøj A, van Beers EJ, Al-Samkari H, et al. Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial. Lancet Haematol. 2022 Oct;9(10):e724-32. Abstract
63. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;(1):CD007798.Full text Abstract
64. Meyer O, Stahl D, Beckhove P, et al. Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm type. Br J Haematol. 1997 Sep;98(4):860-2. Abstract
65. Röth A, Barcellini W, D'Sa S, et al. Sutimlimab in cold agglutinin disease. N Engl J Med. 2021 Apr 8;384(14):1323-34.Full text Abstract
66. Flores G, Cunningham-Rundles C, Newland AC, et al. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol. 1993 Dec;44(4):237-42. Abstract
67. Shah FT, Porter JB, Sadasivam N, et al. Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias. Br J Haematol. 2022 Jan;196(2):336-50.Full text Abstract
68. Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood. 2014 Nov 6;124(19):2930-6.Full text Abstract
Use of this content is subject to our disclaimer